Pharma & Biotech

Inotiv has released its financial results for the first quarter of fiscal year 2026, revealing a concerning trend of expanding...

The publicly traded chapter for CureVac has officially closed. The mRNA specialist's shares have ceased trading on public exchanges after...

Shares of the Danish pharmaceutical giant Novo Nordisk surged by more than 8% on Monday. This significant gain followed a...

The year 2026 represents a critical period for Cellectar Biosciences as it advances its radiopharmaceutical pipeline toward key commercial and...

Eli Lilly has delivered a powerful statement with its latest financial results, sharply contrasting with recent warnings from its key...

The new year has brought both significant momentum and fresh challenges for Jasper Therapeutics. The biopharmaceutical company is navigating a...

Precision BioSciences Inc (DTIL) is navigating a period of pronounced market skepticism following a difficult trading week. Although the company's...

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The cannabis and consumer...

Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations and a broadening...

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed clinical trial data...